Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-11

Clinical Trial Update: Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial update for unresectable stage IIIA/IIIB non-small cell lung cancer; results have been posted as of March 11, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Greg Durm, MD | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-03-11